OMALIZUMAB FOR CHILDREN WITH BRONCHIAL ASTHMA: INDICATIONS TO APPLICATION
Antibodies to IgE are a totally new class of medications currently used to enhance the supervision over severe persistent atopic bronchial asthma. Omalizumab is the most well studied, first and only medication of this group, which is recommended for the application and is allowed for treatment of un...
Saved in:
| Main Author: | T.V. Kulichenko |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Union of pediatricians of Russia
2007-12-01
|
| Series: | Педиатрическая фармакология |
| Online Access: | https://www.pedpharma.ru/jour/article/view/689 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
OMALIZUMAB IN TREATMENT FOR ALLERGIES
by: T.V. Kulichenko
Published: (2007-08-01) -
ECONOMIC ASPECTS OF APPLICATION OF THE RUSSIAN BIOSIMILAR OMALIZUMAB IN PATIENTS WITH ATOPIC BRONCHIAL ASTHMA OF MODERATE TO SEVERE CLINICAL COURSES
by: V. S. Krysanova, et al.
Published: (2021-08-01) -
APPLICATION EFFICIENCY OF MONTELUKAST AMONG CHILDREN SUFFERING FROM BRONCHIAL ASTHMA
by: A.K. Gevorkyan, et al.
Published: (2008-07-01) -
Cost-effectiveness of omalizumab in real world uncontrolled allergic asthma patients
by: A. Arrobas, et al.
Published: (2021-03-01) -
The relationship of spirographic and hematological parameters in children with bronchial asthma
by: E. V. Tush, et al.
Published: (2023-07-01)